Literature DB >> 31085084

Staffing, activities, and infrastructure in 96 specialised adult congenital heart disease clinics in Europe.

Corina Thomet1, Philip Moons2, Werner Budts3, Julie De Backer4, Massimo Chessa5, Gerhard Diller6, Andreas Eicken7, Harald Gabriel8, Pastora Gallego9, Alessandro Giamberti5, Jolien Roos-Hesselink10, Lorna Swan11, Gary Webb12, Markus Schwerzmann13.   

Abstract

BACKGROUND: Clinical guidelines emphasise the need for specialised adult congenital heart disease (ACHD) programmes. In 2014, the working group on Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC) published recommendations on the organisation of specialised care for ACHD. To appraise the extent to which these recommendations were being implemented throughout Europe, we assessed the number of patients in active follow-up and available staff resources in European ACHD programmes.
METHODS: We conducted a descriptive, cross-sectional, paper-based survey of specialised ACHD centres in Europe in late 2017 concerning their centre status in 2016. Data from 96 ACHD centres were analysed. We categorised ACHD programmes into seven different centre types based on their staff resources and composition of interdisciplinary teams.
RESULTS: Only four centres fulfilled all medical and non-medical staffing requirements of the ESC recommendations. Although 60% of the centres offered all forms of medical care, they had incomplete non-medical resources (i.e., specialised nurses, social workers, or psychologists). The participating centres had 226,506 ACHD patients in active follow-up, with a median of 1500 patients per centre (IQR: 800-3400). Six per cent of the patients were followed up in a centre that lacked a CHD surgeon or congenital interventional cardiologist.
CONCLUSIONS: A minority of European ACHD centres have the full recommended staff resources available. This suggests that as of 2016 either ACHD care in Europe was still not optimally organised, or that the latest ESC recommendations were not fully implemented in clinical practice.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adult; Cardiac care facilities; Congenital; Europe; Heart defects; Organisation of care

Mesh:

Year:  2019        PMID: 31085084     DOI: 10.1016/j.ijcard.2019.04.077

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits.

Authors:  Julie De Backer; Lieven Annemans; Ruben Willems; Fouke Ombelet; Eva Goossens; Katya De Groote; Werner Budts; Stéphane Moniotte; Michèle de Hosson; Liesbet Van Bulck; Ariane Marelli; Philip Moons
Journal:  Eur J Health Econ       Date:  2021-04-09

2.  Discontinuity of Cardiac Follow-Up in Young People With Congenital Heart Disease Transitioning to Adulthood: A Systematic Review and Meta-Analysis.

Authors:  Philip Moons; Sandra Skogby; Ewa-Lena Bratt; Liesl Zühlke; Ariane Marelli; Eva Goossens
Journal:  J Am Heart Assoc       Date:  2021-03-04       Impact factor: 5.501

3.  Operational and Ethical Considerations for a National Adult Congenital Heart Disease Database.

Authors:  Elisa A Bradley; Abigail Khan; Demetria M McNeal; Katia Bravo-Jaimes; Amber Khanna; Stephen Cook; Alexander R Opotowsky; Anitha John; Marc Lee; Sara Pasquali; Curt J Daniels; Michael Pernick; James N Kirkpatrick; Michelle Gurvitz
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

4.  Global, regional, and national time trends in mortality for congenital heart disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.

Authors:  Zhanhao Su; Zhiyong Zou; Simon I Hay; Yiwei Liu; Shoujun Li; Huiwen Chen; Mohsen Naghavi; Meghan S Zimmerman; Gerard R Martin; Lauren B Wilner; Craig A Sable; Christopher J L Murray; Nicholas J Kassebaum; George C Patton; Hao Zhang
Journal:  EClinicalMedicine       Date:  2022-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.